Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorn Herrstedt

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 30, 2008
Birth and re-birthSteven M Grunberg, Jorn Herrstedt, Paul J Hesketh
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 29, 2010
Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conferenceFausto Roila, Jorn Herrstedt, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2004
Delayed emesis: moderately emetogenic chemotherapyFausto Roila, David Warr, Rebecca A Clark-Snow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2010
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only)Fausto Roila, David Warr, Matti Aapro, et al.
Cancer|June 24, 2005
Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trialsRichard J Gralla, Ronald de Wit, Jorn Herrstedt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2004
Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapyMark G Kris, Paul J Hesketh, Jorn Herrstedt, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 30, 2008
Birth and re-birthSteven M Grunberg, Jorn Herrstedt, Paul J Hesketh
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 29, 2010
Prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: guideline update and results of the Perugia consensus conferenceFausto Roila, Jorn Herrstedt, Richard J Gralla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2004
Delayed emesis: moderately emetogenic chemotherapyFausto Roila, David Warr, Rebecca A Clark-Snow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 7, 2010
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only)Fausto Roila, David Warr, Matti Aapro, et al.
Cancer|June 24, 2005
Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5HT3 antagonist and a corticosteroid in patients receiving anthracyclines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two Phase III randomized clinical trialsRichard J Gralla, Ronald de Wit, Jorn Herrstedt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 27, 2004
Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapyMark G Kris, Paul J Hesketh, Jorn Herrstedt, et al.
Pageof 1